StageBio will host a booth at the 26th American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting. Each year, the ASGCT Annual Meeting brings gene and cell therapy professionals together with the broader life sciences community to discuss exciting developments, share findings from groundbreaking research and exchange thought-provoking ideas. The 2023 event takes place May 16-20 at the Los Angeles Convention Center in Los Angeles, CA.
We invite you to stop by the StageBio booth #801 and visit our team.
“Our team is looking forward to attending this important scientific meeting and connecting with customers and colleagues in Los Angeles!”
—Lecia Johnson, VP Commercial, StageBio
If you would like to connect with StageBio during ASGCT 2023, contact one of their representatives here.
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving and biorepository services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. StageBio will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 30+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity, and client satisfaction. Learn more at stagebio.com.